ArticleArthritis research & therapy2025

Identifying two pathways to poor prognosis in patients with anti-MDA5 antibodies: insights from prognostic factor and cytokines analysis.

Aya Shimizu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.